Subscribe
Sign in
Home
Events Roundup
Healthtech Pigeon
About us at SomX
Archive
About
Latest
Top
Discussions
#74 - Enzymes, espionage, and experimental excrement
The coffee break biotech roundup, by SomX.
Nov 29
•
Andrew
and
Daisy Makin
2
#73 – Superbug Turkeys, Venom Cures and Camel Antibodies
The coffee break biotech roundup, by SomX.
Nov 22
•
Andrew
and
Belle Taylor
1
3
#72 - The real housewives of bidding wars, regulations, and CRISPR
The coffee break biotech roundup, by SomX.
Nov 15
•
Daisy Makin
and
Belle Taylor
1
1
#71 - Gut instincts, artificial wombs, and the UK brain drain
The coffee break biotech roundup, by SomX.
Nov 9
•
Andrew
#70 – Trick or treat?! Discount drugs and the secrets of eternal youth
The coffee break biotech roundup, by SomX.
Nov 1
•
Andrew
2
1
October 2025
#69 - Collapsing trials, clever pigs & cutthroat exits
The coffee break biotech roundup, by SomX.
Oct 25
•
Andrew
#68 – Heatproof bugs, high-yield bonds & herpes vectors
The coffee break biotech roundup, by SomX.
Oct 18
•
Daisy Makin
and
Belle Taylor
1
#67 – Assassinations, acquisitions, and autoimmune ambition
The coffee break biotech roundup, by SomX.
Oct 11
•
Daisy Makin
and
Belle Taylor
#66 – Irish science, cardiac silence, and fibrotic defiance
The coffee break biotech roundup, by SomX.
Oct 4
•
Daisy Makin
and
Belle Taylor
September 2025
#65 – Feathered dreams and gene therapy schemes
The coffee break biotech roundup, by SomX.
Sep 27
•
Daisy Makin
and
Belle Taylor
1
#64 – Frozen funding, vanishing labs, and stem cells for strokes
The coffee break biotech roundup, by SomX.
Sep 20
•
Andrew
,
Daisy Makin
, and
Belle Taylor
1
#63 – Mind the mitochondria: biotech takes aim at Parkinson’s & ALS
The coffee break biotech roundup, by SomX.
Sep 13
•
Daisy Makin
and
Belle Taylor
3
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts